Claire Martell, CEOWhile the task may seem daunting, Murdock Martell—a boutique consulting firm—makes it a cakewalk. The company specializes in finance, accounting and HR services, guiding startups and emerging companies from seed funding to exit. It also serves various technology sectors, including AI, robotics and semiconductors, offering customized solutions.
Founders are often stretched thin during a startup's early stages. Murdock Martell helps them offload non-core functions and offers essential operational support by simplifying their financial processes. This includes putting together financial statements, providing assistance in cash management and giving insights on the cash burn rate to help companies understand how long their funds will last. These offerings improve the client’s efficiency, leading to financial stability.
“We help the founders put together a very simplistic set of financials, handle ongoing reporting and assist them with their business needs,” says Claire Martell, CEO.
Once a startup begins to grow, hiring becomes a priority. Establishing a strong HR infrastructure is necessary to recruit and retain talented professionals for long-term success and ensure compliance with legal requirements. The company’s dedicated HR resources are perfectly equipped to address these requirements.
Once these companies mature and achieve regulatory approvals from the FDA, they transition from development to commercialization. As companies scale up operations and begin full production, they need efficient inventory tracking, management and supply chain operations to ensure consistent cash flow and meet the lead times to support revenue growth. Rather than moving forward with commercialization, some companies even opt for a sale after the FDA approval. Murdock Martell supports these clients with due diligence, helping them meet the expectations of investors, regulators and buyers.
-
We help the founders put together a very simplistic set of financials, handle ongoing reporting and assist them with their business needs
Once these companies mature and achieve regulatory approvals from the FDA, they transition from development to commercialization. As companies scale up operations and begin full production, they need efficient inventory tracking, management and supply chain operations to ensure consistent cash flow and meet the lead times to support revenue growth. Rather than moving forward with commercialization, some companies even opt for a sale after the FDA approval. Murdock Martell supports these clients with due diligence, helping them meet the expectations of investors, regulators and buyers.
One of Murdock Martell’s standout features is its variable cost model, which is adjusted based on client needs. This helps minimize costs, especially while waiting for FDA approval or early commercialization when less back-office support is required.
It creates a staffing structure to complement this cost efficiency by pairing junior professionals with senior advisors experienced at handling complex tasks like financial projections and board meetings. On the other hand, junior team members, typically degreed accountants, handle most day-to-day operations at a lower bill rate, ensuring a balance in cost efficiency and expertise.
This structure has helped Murdock Martell build a strong reputation for driving startup growth and success. Many of these companies have gone public or been acquired by industry leaders like Boston Scientific and Becton Dickinson.
In one instance, a medtech startup preparing for an initial public offering (IPO) reached out to Murdock Martell for support. Although the startup did not have a dedicated chief financial officer, the Murdock Martell team successfully guided them through the IPO process. It helped them overcome financial and regulatory challenges, ensuring a smooth transition to becoming a publicly traded company. This partnership played an essential role in the client's success, highlighting the company’s ability to provide high-level financial strategy and support during pivotal growth stages.
For life sciences and medtech startups, working with Murdock Martell is not the same as outsourcing backend processes to a service provider. They gain a trusted advisor familiar with the intricacies of their industry. It becomes a key partner by supporting their journey from development to exit.
Empowering Life Science Startups with Strategic Finance, Accounting and HR
Claire Martell, CEO
At Murdock Martell, our vision is to empower life science and tech founders by taking the weight of finance, accounting, and HR off their shoulders—so they can stay focused on what matters most: advancing innovation, securing funding, and improving lives. We bring seasoned expertise, flexible support, and trusted partnership to every stage of their growth
Deep Dive
Bridging Science and Scale: Rethinking Financial Leadership in Life Sciences
Life science companies often begin with strong scientific conviction yet limited business infrastructure. Founders are equipped to advance research, validate hypotheses and build technical teams, but the transition into a functioning enterprise introduces pressures that extend beyond the lab. Financial planning, workforce structuring and regulatory alignment begin to shape outcomes as much as the science itself. This shift exposes a persistent gap: the ability to translate innovation into a financially viable, fundable and scalable business.
Early-stage organizations face a layered set of constraints. Funding pathways are complex, ranging from grant mechanisms with administrative overhead to equity financing that demands forward-looking models and disciplined reporting. Internal systems rarely evolve at the pace required, leaving leadership teams balancing development priorities with back-office responsibilities that dilute focus. Growth introduces further strain, as hiring, compliance and cross-state operations require coordination that many young firms are not structured to manage.
What distinguishes effective financial partners in this environment is not breadth alone but the ability to align closely with a company’s stage and trajectory. A strong provider integrates into the business early, assuming responsibility for accounting, forecasting and cash management in a way that frees scientific leadership to concentrate on product development. Over time, that relationship evolves rather than resets. Support expands to include audit readiness, due diligence for financing rounds and coordination with external advisors, reflecting a continuity that mirrors the company’s lifecycle rather than a series of disconnected engagements.
Flexibility in engagement becomes critical as companies grow. Early reliance on fractional support allows organizations to access senior financial expertise without committing to full-time hires. As internal teams develop, the external partner adjusts its role, scaling back in some areas while remaining embedded in others. This ability to adapt ensures that financial oversight remains consistent even as responsibilities transition in-house, avoiding the disruption that often accompanies rapid expansion.
Another defining characteristic lies in how financial advisory extends beyond numbers into infrastructure. Life science firms frequently require guidance on hiring frameworks, compliance standards and operational setup across jurisdictions. A partner that can support onboarding, workforce policies and expansion logistics reduces fragmentation within the organization. This integrated approach keeps financial planning connected to broader business realities, rather than operating in silos.
Technology plays a supporting role but requires disciplined evaluation. The rapid emergence of new tools has introduced both opportunity and risk, particularly in environments where data integrity and security are paramount. Providers that actively assess and refine their technology stacks while remaining open to client preferences strike a balance between innovation and stability. This ensures that automation enhances efficiency without compromising control or compliance expectations.
Murdock Martell reflects these characteristics through its focus on life science and technology clients and its emphasis on long-term engagement. It positions itself as a fractional finance partner that integrates across accounting, forecasting, HR support and transaction readiness, allowing companies to delegate critical business functions while maintaining strategic oversight. Its model adapts to client growth, often transitioning responsibilities as internal teams are built, while continuing to support areas that require specialized expertise. Its involvement in funding preparation, audit readiness and lifecycle events such as acquisitions or wind-downs demonstrates an ability to remain relevant through multiple stages of a company’s development. This continuity, combined with a client-led approach to service design, places it among the more aligned options for organizations navigating the shift from scientific innovation to sustainable enterprise.
...Read more
Life Science Outsourced CFO Info
Q1
What distinguishes Murdock Martell among Top Life Sciences Consulting Providers?
Murdock Martell has earned recognition among Top Life Sciences Consulting Providers through its specialized expertise in executive search and leadership advisory for pharmaceutical, biotechnology and medical technology organizations. The company focuses on helping life sciences businesses build leadership teams capable of supporting scientific innovation, commercialization and long-term organizational growth. Its consulting model combines industry-specific recruitment knowledge with strategic advisory services tailored to highly specialized healthcare sectors. Murdock Martell also differentiates itself through a relationship-driven approach that emphasizes long-term leadership alignment rather than transactional hiring support. (lifesciencesreview.com )
Q2
How does Murdock Martell approach life sciences consulting and executive search?
Leadership strategy and sector expertise shape the company’s consulting philosophy. Unlike many Life Sciences Consulting Providers that offer generalized recruitment services across multiple industries, Murdock Martell concentrates exclusively on life sciences leadership placement and advisory support. The company works closely with clients to understand organizational culture, scientific direction and business priorities before identifying executive candidates. Its process also incorporates market intelligence, talent mapping and succession planning to help organizations strengthen leadership continuity and operational direction within highly regulated healthcare environments. (lifesciencesreview.com )
Q3
Why is Murdock Martell relevant to today’s life sciences industry?
Rapid innovation in biotechnology, pharmaceuticals and medical technology has increased demand for experienced leadership capable of navigating scientific, regulatory and commercial complexity. Murdock Martell addresses this need by helping life sciences organizations identify executives with the expertise required to guide research, commercialization and operational growth. Among Life Sciences Consulting Providers, the company stands out for its deep understanding of leadership requirements across emerging biotech ventures and established healthcare organizations. Its ability to connect specialized talent with evolving business needs strengthens organizational readiness in competitive healthcare markets. (lifesciencesreview.com )
Q4
What role does industry expertise play in Murdock Martell’s consulting model?
Sector-specific knowledge remains central to Murdock Martell’s advisory approach. The company’s leadership team brings extensive experience within pharmaceuticals, biotechnology and medical devices, allowing it to understand the scientific and commercial demands shaping executive hiring decisions. This expertise helps the company identify candidates capable of supporting innovation-driven healthcare organizations across research, clinical development, commercialization and operational leadership functions. Life Sciences Consulting Providers often differentiate themselves through industry specialization, and Murdock Martell reinforces that distinction through focused expertise in healthcare leadership strategy and executive recruitment. (lifesciencesreview.com )
Q5
How does Murdock Martell support clients throughout the hiring process?
Collaborative engagement forms an important part of the company’s client support strategy. Murdock Martell works closely with boards, investors and executive leadership teams throughout candidate identification, evaluation and onboarding processes to ensure long-term alignment between organizations and leadership hires. Its services extend beyond candidate sourcing into advisory support involving succession planning, market insights and organizational leadership development. Among Life Sciences Consulting Providers, Murdock Martell distinguishes itself through personalized communication, industry-informed guidance and a consultative process designed around long-term business objectives rather than short-term placement goals. (lifesciencesreview.com )
Q6
Why has Murdock Martell gained recognition in life sciences consulting?
Industry recognition for Murdock Martell reflects its consistent focus on specialized healthcare leadership consulting and executive search excellence. The company has built strong relationships across biotechnology, pharmaceutical and medical technology sectors by helping organizations secure leaders capable of advancing innovation and business growth. Its reputation also stems from its ability to understand the strategic demands facing life sciences companies at different stages of development. This combination of sector expertise, leadership advisory capabilities and relationship-focused consulting continues to strengthen Murdock Martell’s standing among Life Sciences Consulting Providers. (lifesciencesreview.com )
